Mirae Asset Global Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Mirae Asset Global Investments’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-39,283	Closed	-$488K	–	683
2016 Q4	$488K	Buy	+39,283	New	+$473K	0.01%	401

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Mirae Asset Global Investments's ARIA Position: Q1 2017 in Review

Mirae Asset Global Investments sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 39,283 shares — an estimated $488K sold.

Mirae Asset Global Investments first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $488K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Mirae Asset Global Investments reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Mirae Asset Global Investments sold 39,283 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $488K.
Mirae Asset Global Investments first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Mirae Asset Global Investments's Ariad Pharmaceuticals Inc position peaked at $488K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Mirae Asset Global Investments's 13F filing for Q1 2017, filed 9 May 2017.